Table 4 Univariate analysis of DFS among patients with stage I OEC
From: Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma
Variable | Category | N(%) | DFS(Median(IQR)) | DFS rate(%) | P |
|---|---|---|---|---|---|
Age y | <50 | 45 (57.7%) | 75.0 (54.0,102.0) | 86.7% | 0.2563 |
> = 50 | 33 (42.3%) | 56.0 (30.0,81.0) | 75.76 | ||
Menopausal status | Pre | 47 (60.3%) | 82.0 (44.0,109.0) | 82.98 | 0.0526 |
Post | 31 (39.7%) | 56.0 (25.0,78.0) | 70.97 | ||
Gravidity | 0 | 12 (15.38) | 106.5 (63,143) | 83.33 | 0.2028 |
> = 1 | 66 (84.62) | 65.5 (36,90) | 77.27 | ||
Parity | 0 | 18 (23.08) | 85 (63,131) | 83.33 | 0.1870 |
> = 1 | 60 (76.92) | 65 (35,94) | 76.67 | ||
CA125 normal | Yes | 9 (11.5%) | 70 (65 ~ 102) | 88.89 | 0.3948 |
No | 69 (88.5%) | 67 (34 ~ 98) | 76.81 | ||
Hypertension | Yes | 11 (14.1%) | 57 (12 ~ 81) | 81.82 | 0.8304 |
No | 67 (85.90%) | 70 (38 ~ 102) | 77.61 | ||
Tumor side | Unilateral | 63 (80.77%) | 67 (30 ~ 101) | 76.19 | 0.4040 |
Bilateral | 15 (19.23%) | 71 (38 ~ 102) | 86.67 | ||
Tumor size | <10 | 45 (57.69%) | 75 (44 ~ 102) | 77.78 | 0.4971 |
≥10 | 33 (42.31%) | 56 (16 ~ 84) | 78.79 | ||
Endometriosis | Yes | 23 (29.5%) | 66 (36 ~ 90) | 86.96 | 0.3539 |
No | 55 (70.5%) | 69 (34 ~ 102) | 74.55 | ||
Endometrial disorders | Yes | 21 (26.9%) | 65 (12 ~ 102) | 85.71 | 0.2406 |
No | 57 (73.1%) | 68 (38 ~ 98) | 75.44 | ||
Stage | IA + IB | 26 (33.3%) | 67.0 (39.0,109.0) | 88.46 | 0.0583 |
IC | 52 (66.7%) | 67.5 (29.5,99.5) | 73.08 | ||
Mixed histology | No | 73 (93.59) | 69 (36,102) | 79.45 | 0.1295 |
Yes | 5 (6.419) | 38 (36,65) | 60 | ||
Grade | G1 | 35 (44.8%) | 82 (59, 117) | 85.71 | 0.0008* |
G2 | 26 (33.3%) | 64 (29, 98) | 84.62 | ||
G3 | 17 (21.8%) | 39 (28, 66) | 52.94 | ||
Cytology of ascites | Negative | 70 (89.74) | 68.5 [36,101] | 81.43 | 0.0253* |
Positive | 8 (10.26) | 61.5 [21.5,89.5] | 50 | ||
ER | Negative | 12 (32.43) | 73 [47,102] | 83.33 | 0.7491 |
Positive | 25 (67.57) | 66 [44,86] | 80 | ||
PR | Negative | 8 (21.62) | 68 [49.5,88.5] | 87.5 | 0.6476 |
Positive | 29 (78.38) | 67 [44,90] | 79.31 | ||
Lymphadenectomy | Yes | 71 (91.0%) | 68 (36,102) | 81.69 | 0.0041* |
No | 7 (9.0%) | 38 (9, 101) | 42.86 | ||
Para-aotic Lymphadenectomy | No | 27 (37.5) | 71 [44,131] | 77.78 | 0.8075 |
Yes | 45 (62.5) | 63 [30,90] | 82.22 | ||
Numbers of dissected Lymphadenectomy | <17 | 34 (43.59) | 72.5 [39,131] | 76.47 | 0.8693 |
> = 17 | 38 (48.72) | 64 [29,84] | 84.21 | ||
Chemotherapygroup | <4 | 21 (30.9%) | 82 (62–121.5) | 90.50 | 0.056 |
≥4 | 47 (69.1%) | 65 (30 ~ 101) | 72.34 |